Status:
UNKNOWN
Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency
Lead Sponsor:
Mansoura University
Conditions:
Benign Prostatic Hyperplasia
Eligibility:
MALE
50+ years
Phase:
PHASE4
Brief Summary
Patients presented for BPH surgery at our out patient clinic will be assessed for abnormal bleeding profile. Patients with bleeding tendency will be offered either HoLEP or Greenlight laser PVP based...
Detailed Description
Elderly patients with bleeding tendency either secondary; 1. Strict antiplatelet intake 2. Strict anticoagulant intake 3. uncorrected natural bleeding tendency e.g; patients with liver cell failure a...
Eligibility Criteria
Inclusion
- BPH patients candidate for transurethral prostate surgery after failure of medical treatment
- Perioperative uncorrected Blleding tendency
- patients with naturally induced uncorrectable bleeding tendency;
- platelet count less than 100000/mm3
- INR more than 1.5
- Patients on oral antiplatlet that deemed unsafe to stop prior to surgery as per intenist
- Patients on oral anticoagulant that deemed unsafe to stop prior to surgery as per intenist
Exclusion
- Correctable bleeding tendency
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2016
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT02293759
Start Date
October 1 2014
End Date
September 1 2016
Last Update
March 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology Center
Al Mansurah, Aldakahlia, Egypt, 35516